Need Help?

Study 15-09-2023 Test 1

Study desc 15-09-2023 Test 1

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000000148 454 GS 2
Publications Citations
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.
Blood 143: 2024 822-832
8
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Blood 145: 2025 708-719
0